comparemela.com

Page 7 - Novartis Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novartis Pharma AG: Novartis maintains growth momentum and confirms FY 22 Group guidance

Ad hoc announcement pursuant to Art. 53 LR Q3 sales grew +4% cc1 (-4% USD) Innovative Medicines (IM) sales grew +4% cc (-3% USD), driven by key growth brands including: Entresto (+31% cc), Kesimpta

MAPS PBC Elects Jeff George as Chairman of the Board of Directors

vimarsana © 2020. All Rights Reserved.